Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary BioScrip Announces CFO Transition
Appoints Stephen M. Deitsch as Senior Vice President, Chief Financial Officer and Treasurer DENVER , April 20, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced the
Toggle Summary BioScrip To Host First Quarter 2017 Results Call
DENVER , April 17, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its first quarter 2017 financial results on Thursday, May 4, 2017 , before the opening of the U.S. financial markets. Daniel E. Greenleaf , President and Chief Executive Officer,
Toggle Summary BioScrip Announces Meeting with Investors
Company Expects Improved Profitability Following Termination of Agreement with UnitedHealthcare DENVER , March 27, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced members
Toggle Summary BioScrip Reports Fourth Quarter and Full-Year 2016 Financial Results
Q4 Consolidated Revenue of $240.1 Million, loss from continuing operations net of income taxes of ($5.2) million and Adjusted EBITDA of $9.5 Million DENVER , March 03, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (“BioScrip” or the “Company”) today announced its fourth quarter and
Toggle Summary BioScrip Raises Approximately $5 million in Private Placement of Common Stock
DENVER , March 02, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that it entered into a Stock Purchase Agreement on March 1, 2017 , for the sale of an aggregate of
Toggle Summary BioScrip To Host Fourth Quarter and Full-Year 2016 Results Call
DENVER , Feb. 15, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its fourth quarter and full-year 2016 financial results on Friday, March 3, 2017 , before the opening of the U.S. financial markets. Daniel E.
Toggle Summary BioScrip, Inc. Joins Coalition to Advocate for Vulnerable Medicare Patients Losing Access to Home Infusion Care
Calls on Congress to Fix Unintended Consequence of 21 st Century Cures Act; Encourages Patients, Families, Others to Join Outreach DENVER --(BUSINESS WIRE)--Feb. 6, 2017-- BioScrip, Inc. (NASDAQ:BIOS), a leading national provider of infusion and home care management solutions, announced today it
Toggle Summary BioScrip Announces Amendment to Credit Agreement and New Senior Loan Facility
DENVER , Jan. 06, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that it has entered into an agreement to amend its existing Credit Agreement (the “Amendment”), dated
Toggle Summary BioScrip Provides Business Update and Outlines Plan to Increase Liquidity
Provides Update on Fourth Quarter 2016 and Comments on Business Impact of 21st Century Cures Act DENVER , Dec. 14, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that it
Toggle Summary BioScrip Reports Third Quarter 2016 Financial Results
Q3 Consolidated Revenue of $224.5 Million, Loss from continuing operations, net of income taxes of $(11.1) Million and Adjusted EBITDA of $3.5 Million DENVER , Nov. 07, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (“BioScrip” or the “Company”) today announced financial results for the